Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Lymphocytic Colitis
NCT00180050Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2002
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Lymphocytic Colitis (LC) comparing Budesonide with Placebo (2 arms). Primary endpoint: Proportion of patients in clinical remission at 6 weeks. Started Jan 2002; status: completed.
02
Drugs
budesonide
03
Conditions
Lymphocytic Colitis (LC)
Beyond the preview
Go deeper on NCT00180050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180050.